» Articles » PMID: 33809114

Plant-Derived -β-Caryophyllene Boosts Glucose Metabolism and ATP Synthesis in Skeletal Muscle Cells Through Cannabinoid Type 2 Receptor Stimulation

Overview
Journal Nutrients
Date 2021 Apr 3
PMID 33809114
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Skeletal muscle plays a pivotal role in whole-body glucose metabolism, accounting for the highest percentage of glucose uptake and utilization in healthy subjects. Impairment of these key functions occurs in several conditions including sedentary lifestyle and aging, driving toward hyperglycemia and metabolic chronic diseases. Therefore, strategies pointed to improve metabolic health by targeting skeletal muscle biochemical pathways are extremely attractive. Among them, we focused on the natural sesquiterpene and cannabinoid type 2 (CB2) receptor agonist β-caryophyllene (BCP) by analyzing its role in enhancing glucose metabolism in skeletal muscle cells. Experiments were performed on C2C12 myotubes. CB2 receptor membrane localization in myotubes was assessed by immunofluorescence. Within glucose metabolism, we evaluated glucose uptake (by the fluorescent glucose analog 2-NBDG), key enzymes of both glycolytic and oxidative pathways (by spectrophotometric assays and metabolic radiolabeling) and ATP production (by chemiluminescence-based assays). In all experiments, CB2 receptor involvement was tested with the CB2 antagonists AM630 and SR144528. Our results show that in myotubes, BCP significantly enhances glucose uptake, glycolytic and oxidative pathways, and ATP synthesis through a CB2-dependent mechanism. Giving these outcomes, CB2 receptor stimulation by BCP could represent an appealing tool to improve skeletal muscle glucose metabolism, both in physiological and pathological conditions.

Citing Articles

Pharmacology of Non-Psychoactive Phytocannabinoids and Their Potential for Treatment of Cardiometabolic Disease.

Wainwright C, Walsh S Handb Exp Pharmacol. 2024; 287():61-93.

PMID: 39235486 DOI: 10.1007/164_2024_731.


Beta-Caryophyllene Modifies Intracellular Lipid Composition in a Cell Model of Hepatic Steatosis by Acting through CB2 and PPAR Receptors.

Scandiffio R, Bonzano S, Cottone E, Shrestha S, Bossi S, De Marchis S Int J Mol Sci. 2023; 24(7).

PMID: 37047034 PMC: 10094507. DOI: 10.3390/ijms24076060.


Antidiabetic Potential of Volatile Cinnamon Oil: A Review and Exploration of Mechanisms Using In Silico Molecular Docking Simulations.

Stevens N, Allred K Molecules. 2022; 27(3).

PMID: 35164117 PMC: 8840343. DOI: 10.3390/molecules27030853.


Trimetazidine Attenuates Heart Failure by Improving Myocardial Metabolism via AMPK.

Shu H, Hang W, Peng Y, Nie J, Wu L, Zhang W Front Pharmacol. 2021; 12:707399.

PMID: 34603021 PMC: 8479198. DOI: 10.3389/fphar.2021.707399.

References
1.
Al-Taee H, Azimullah S, Meeran M, Alaraj Almheiri M, Al Jasmi R, Tariq S . β-caryophyllene, a dietary phytocannabinoid attenuates oxidative stress, inflammation, apoptosis and prevents structural alterations of the myocardium against doxorubicin-induced acute cardiotoxicity in rats: An in vitro and in vivo study. Eur J Pharmacol. 2019; 858:172467. DOI: 10.1016/j.ejphar.2019.172467. View

2.
Gothandam K, Ganesan V, Ayyasamy T, Ramalingam S . Protective effect of theaflavin on glycoprotein components and TCA cycle enzymes in high-fat diet and streptozotocin-induced diabetic rats. J Basic Appl Zool. 2020; 80(1):43. PMC: 7091795. DOI: 10.1186/s41936-019-0115-1. View

3.
Fidyt K, Fiedorowicz A, Strzadala L, Szumny A . β-caryophyllene and β-caryophyllene oxide-natural compounds of anticancer and analgesic properties. Cancer Med. 2016; 5(10):3007-3017. PMC: 5083753. DOI: 10.1002/cam4.816. View

4.
Carnagarin R, Dharmarajan A, Dass C . Molecular aspects of glucose homeostasis in skeletal muscle--A focus on the molecular mechanisms of insulin resistance. Mol Cell Endocrinol. 2015; 417:52-62. DOI: 10.1016/j.mce.2015.09.004. View

5.
Campia I, Lussiana C, Pescarmona G, Ghigo D, Bosia A, Riganti C . Geranylgeraniol prevents the cytotoxic effects of mevastatin in THP-1 cells, without decreasing the beneficial effects on cholesterol synthesis. Br J Pharmacol. 2009; 158(7):1777-86. PMC: 2801219. DOI: 10.1111/j.1476-5381.2009.00465.x. View